Claire Poll Verona Pharma PLC (VRNA) insider trading activity

Claire Poll is General Counsel of Verona Pharma plc. Currently has a direct ownership of 1.62 Million shares of VRNA, which is worth approximately $55.1 Million. The most recent transaction as insider was on Feb 01, 2024, when has been sold 103,408 shares (Ordinary Shares) at a price of $2.29 per share, resulting in proceeds of $236,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.62M

0% 3M change

1.45% 12M change

Total Value Held $55.1 Million

Claire Poll Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2024	SELL Payment of exercise price or tax liability	$236,804 $2.29 p/Share	103,408 Reduced 5.61%	1,740,079 Ordinary Shares
Feb 01 2024	SELL Bona fide gift	-	116,592 Reduced 6.7%	1,623,487 Ordinary Shares
Nov 01 2023	SELL Bona fide gift	-	196,096 Reduced 10.64%	1,647,391 Ordinary Shares
Nov 01 2023	SELL Payment of exercise price or tax liability	$302,592 $1.74 p/Share	173,904 Reduced 8.62%	1,843,487 Ordinary Shares
Oct 20 2023	BUY Grant, award, or other acquisition	-	200,000 Added 9.02%	2,017,391 Ordinary Shares
Aug 07 2023	SELL Bona fide gift	-	89,976 Reduced 4.72%	1,817,391 Ordinary Shares
Aug 07 2023	SELL Open market or private sale	$3,734 $2.47 p/Share	1,512 Reduced 0.08%	1,907,367 Ordinary Shares
Aug 04 2023	SELL Open market or private sale	$65,880 $2.5 p/Share	26,352 Reduced 1.36%	1,908,879 Ordinary Shares
Aug 03 2023	SELL Open market or private sale	$52,344 $2.54 p/Share	20,608 Reduced 1.05%	1,935,231 Ordinary Shares
Aug 02 2023	SELL Open market or private sale	$33,524 $2.59 p/Share	12,944 Reduced 0.66%	1,955,839 Ordinary Shares
Aug 01 2023	SELL Open market or private sale	$49,869 $2.68 p/Share	18,608 Reduced 0.94%	1,968,783 Ordinary Shares
May 01 2023	SELL Open market or private sale	$207,370 $2.58 p/Share	80,376 Reduced 3.9%	1,979,063 Ordinary Shares
Feb 01 2023	SELL Bona fide gift	-	152,000 Reduced 6.87%	2,059,439 Ordinary Shares
Jan 20 2023	BUY Exercise of conversion of derivative security	-	178,800 Added 7.48%	2,211,439 Ordinary Shares
Nov 22 2022	SELL Bona fide gift	-	170,000 Reduced 7.72%	2,032,639 Ordinary Shares
Sep 26 2022	BUY Grant, award, or other acquisition	-	800,000 Added 23.79%	2,563,055 Ordinary Shares
Aug 21 2022	SELL Bona fide gift	-	90,104 Reduced 3.93%	2,202,639 Ordinary Shares
Aug 01 2022	SELL Payment of exercise price or tax liability	$53,530 $0.67 p/Share	79,896 Reduced 4.34%	1,763,055 Ordinary Shares
May 22 2022	SELL Bona fide gift	-	90,104 Reduced 3.78%	2,292,743 Ordinary Shares
May 01 2022	SELL Payment of exercise price or tax liability	$41,546 $0.52 p/Share	79,896 Reduced 4.16%	1,842,951 Ordinary Shares
Feb 22 2022	SELL Bona fide gift	-	90,104 Reduced 3.64%	2,382,847 Ordinary Shares
Feb 01 2022	SELL Payment of exercise price or tax liability	$62,319 $0.78 p/Share	79,896 Reduced 3.99%	1,922,847 Ordinary Shares
Nov 21 2021	SELL Bona fide gift	-	90,104 Reduced 3.52%	2,472,951 Ordinary Shares
Nov 01 2021	SELL Payment of exercise price or tax liability	$51,133 $0.64 p/Share	79,896 Reduced 3.84%	2,002,743 Ordinary Shares
Aug 01 2021	SELL Bona fide gift	-	360,400 Reduced 14.75%	2,082,639 Ordinary Shares

Claire Poll

General Counsel

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verona Pharma plc

Track Activities on VRNA

Account